Category Archives: Z Medical centers

Crystalloid “Balanced Lactated Ringer’s” IV solution is safer to the kidneys

March 1, 2018- Interviewed by Steven E. Greer, MD We interviewed Vanderbilt’s Todd Rice, MD about his NEJM papers that showed crystalloid, or

Posted in - NEJM, Cardiac surgery, Cardiology, Emergency medicine, General surgery, Internal Medicine, Neurology, Neurosurgery, Obstetrics and Gynecology, Oncology, Orthopedic surgery, Pediatrics, Plastic surgery, Sports medicine, Trauma Surgery, Urology, Vanderbilt, Vascular Surgery | Leave a comment

How to beat the virus with early treatment

July 22, 2021- by Steven E. Greer, MD I woke up yesterday with a slight malaise and I sneezed once. I knew I had come down with a virus

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, Duke, Emergency medicine, Geriatrics, Infectious disease, Internal Medicine, Pediatrics, Primary care medicine, Pulmonology | Leave a comment

Interview with Simon Townshend about the Daltrey/Townshend Teen Cancer Program

The Daltrey Townshend teenage and young adult cancer center at UCLA

Posted in Oncology, UCLA | Leave a comment

Violent video games and aggressive behavior

March 30, 2014- Interviewed by Steven E. Greer, MD A recent JAMA paper connects the dots between violent video games and aggressive behavior.

Posted in - JAMA, - Policy, Congress, Emergency medicine, Iowa State, Pediatrics, Psychology Psychiatry, Trauma Surgery | Leave a comment

“Discharged Alive”

February 21, 2022- by Steven E. Greer, MD Last December, both of my parents were admitted for almost two-weeks at the Ohio State University

Posted in - Policy, Geriatrics, Infectious disease, Internal Medicine, Neurology, Ohio State, Psychology Psychiatry, Rehab | Leave a comment

Why Indian Point nuclear power plant needs to be shut down

April 29, 2017- by Steven E. Greer, MD I have long been a critic of the overuse of CT-scans due to the radiation risks and costs. I’m not sure why,

Posted in - Opinion, - Policy, CDC, Congress, Emergency medicine, Obstetrics and Gynecology, Radiology, UC San Francisco | Leave a comment

Robotic surgery and controversies

January 24, 2014- Dr. Dutson gives an update on the referral patterns and safety concerns over the Da Vinci system.

Posted in General surgery, UCLA | Leave a comment

I just shook hands with a face transplant patient and did not know it

January 21, 2015- By Steven E. Greer, MD I was in the process of being given a personal tour of the new facilities of the NYU Institute of

Posted in - Opinion, NYU, Plastic surgery | Leave a comment

The best hospitals in the country are losing money. Why?

August 12, 2019- by Steven E. Greer, MD In the course of working on a medical book for the patient population, I just discovered this 2017 Forbes article that explains

Posted in - Policy, Cleveland Clinic, CMS, Columbia, Congress, Cornell, Harvard, NYU, Ohio State, UCLA, Univ Miami, Z Medical centers | Comments Off on The best hospitals in the country are losing money. Why?

Vaccinations that all adults should have

Interviewed by Steven E. Greer, MD William Schaffner, MD, Professor and Chair of the Department of Preventive Medicine at Vanderbilt University

Posted in - Policy, Infectious disease, Pediatrics, Primary care medicine, Vanderbilt | Leave a comment

The NIH Human Microbiome Project

March 31, 2010- Produced and interviewed by Steven E. Greer, MD Infectious disease specialist Dr. Vincent Young from the University of Michigan discusses the

Posted in Infectious disease, Michigan, NIH | Leave a comment

The ISCHEMIA trial PI, Judith Hochman, makes egregiously unfounded statements on national TV

November 17, 2019- by Steven E. Greer, MD The big news from the 2019 American Heart Association meeting is the large trial known by the acronym ISCHEMIA.

Posted in - Opinion, - Pharma, Cardiac surgery, Cardiology, Congress, FDA, Internal Medicine, NYU, VA | 1 Comment

Effects of Spaceflight on Astronaut Brain Structure as Indicated on MRI

November 22, 2017 – Interviewed by Steven E. Greer, MD We interviewed Donna Roberts, MD of the Medical University of South Carolina about her NEJM paper

Posted in - NEJM, Medical University of South Carolina, Neurology, Neurosurgery, Ophthalmology, Radiology | Leave a comment

Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital.

Dean and CEO of Johns Hopkins Medicine Paul Rothman December 11, 2018- by Steven E. Greer, MD Ranking colleges and medical centers is a futile, highly subjective, and ludicrous endeavor. Nevertheless,

Posted in - Policy, Cardiac surgery, Cardiology, Columbia, Johns Hopkins, Pediatrics | 3 Comments

Don Berwick, MD: Waste in the American Healthcare System

Dr. Berwick, former Director of CMS and former President and CEO of IHI, discusses the percentage

Posted in CMS, Congress, Harvard | Leave a comment

Benjamin Sommers, MD PhD: Expansion of Medicaid and impact on mortality rates

September 7, 2012

Posted in CMS, Harvard | Leave a comment

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

February 27, 2017- interviewed by Steven E. Greer, MD We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber,

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment

Preventing HIV infection

July 28, 2014- Interviewed by Steven E. Greer, MD Rajesh Tim Gandhi, MD of the Massachusetts General Hospital discusses the NEJM review paper he co-wrote

Posted in - Biotech, - NEJM, - Pharma, General surgery, Harvard, Infectious disease, Primary care medicine | Leave a comment

Eluxadoline (Viberzi) to treat Irritable Bowel Syndrome

January 20, 2016- Produced, Interviewed by Steven E. Greer, MD We interviewed Anthony Lembo, MD of The Beth Israel Deaconess Hospital to discuss his

Posted in - NEJM, - Pharma, Gastroenterology and liver, Harvard | Leave a comment

Paul Richardson, MD: Current Therapies for Multiple Myeloma

December 15, 2015- Interviewed by Steven Greer, MD Dr. Paul Richardson, Clinical Director of the Multiple Myeloma Center at Harvard’s Dana-Farber

Posted in - Biotech, - Pharma, Harvard, Oncology | Leave a comment